Dr Melanie Madhani

Dr Melanie Madhani

Institute of Cardiovascular Sciences
Senior Lecturer in Cardiovascular Medicine

Contact details

Institute of Cardiovascular Sciences
College of Medical and Dental Sciences
University of Birmingham
B15 2TT

Dr Melanie Madhani is a Senior Lecturer in Cardiovascular Medicine within the Institute of Cardiovascular Sciences. 

Dr Madhani works on understanding the mechanisms of heart disease, and leads a translational research group in myocardial infarction and heart failure. Her research group is assessing novel pharmacological strategies to protect the heart against from ischaemia reperfusion injury and heart failure, with scientists and clinical research fellows working together from “bench to bedside, and back again”.  


Dr Melanie Madhani graduated from the University of Wales College Of Medicine in 1998 and obtained a PhD in Cardiovascular Sciences from the Ivy League School, Dartmouth College, New Hampshire, USA and University of Wales in 2002. She then joined University College London (UCL) as a British Heart Foundation research fellow, to work under Dr Adrian Hobbs. Here, she investigated the role of nitric oxide (NO) in cardiovascular diseases. Dr Madhani was awarded a UCL Bogue Fellowship to work with Nobel Laureate Dr Louis Ignarro, University of California, LA, USA. In 2005, she joined Dr Philip Eaton's research group at The Rayne Institute, King's College London, where she broadened her experience in cardiac physiology in order to complement her vascular knowledge and skills into NO regulation during myocardial ischaemia reperfusion injury. In 2009, the University of Birmingham appointed Dr Madhani and is a Senior Lecturer in Cardiovascular Medicine. Here, she continues with her research  in this field and collaborates with Prof Frenneaux (University of East Anglia), Prof Feelisch (University of Southampton), Prof Horowitz (Queen Elizabeth Hospital, University of Adelaide, Australia), and Prof Underwood (Prince of Wales Hospital, Chinese University of Hong Kong). Dr Madhani is also the Treasurer for the British Society for Cardiovascular Research and holds an Adjunct Honorary Assistant Professor position at the Department of Medicine and Therapeutics, Chinese University of Hong Kong. 


  • Deputy Module Co-ordinator for 3rd Year BMed Sc module: Cardiovascular
  • Lectures for Cardiovascular modules to 1st and 3rd Year BMed Sc, MPharm,  MBChB, Graduate Entry Course in Medicine and MRes  programmes
  • Personal Mentor for MBChB
  • Postgraduate supervision for basic scientists and clinicians 


Dr Madhani leads a research group to characterise the functional deterioration within the heart following myocardial infarction and heart failure. Novel pharmacological methods of improving outcomes are also investigated. Her research group is investigating: 

  • Novel protective strategies against ischaemia reperfusion in patients undergoing coronary artery bypass grafting surgery
  • Assessing the protective role of nitrite against myocardial reperfusion injury and heart failure
  • Perhexiline and cardiac metabolism in heart failure

Other activities

  • Treasurer for the British Society for Cardiovascular Research (2014-2017)
  • Adjunct Assistant Professor at the Department of Medicine and Therapeutics, Chinese University of Hong Kong
  • International Strategy Development for the Institute of Cardiovascular Sciences (2016)
  • Review Editor of Frontiers in Clinical & Translational Physiology (2009- present)
  • Associate Editor for International Journal for Pharmacology & Therapeutics (2006-2013)
  • Bulletin Editor for the British Society for Cardiovascular Research (2009-2013)


Loudon BL, Noordali H, Gollop ND, Frenneaux MP and Madhani M. Present and Future Pharmacotherapeutic Agents in Heart Failure: An Evolving Paradigm. British Journal of Pharmacology.   2016 Mar 18

Arif S, Borgognone A, O’Sullivan A, Lai E, Menon A, Sharma V, Beadle R, Feelisch M, Horowitz J, Bonser RS, Frenneaux MP and Madhani M. Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in humans. British Journal of Pharmacology. 2015. July: 172 (13):3341-52.

Ormerod JOM, Arif S, Mukadam M, Evans JDW, Beadle R, Fernandez BO, Bonser RS, Feelisch M, Madhani M*, Frenneaux MP* - *joint last authorsShort-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients. Circulation Heart Failure. 2015 May: 8(3): 565-71.

Bailey JC, Feelisch M, Horowitz JD, Frenneaux MP and Madhani M. Pharmacology and therapeutic role of inorganic nitrite and nitrate in vasodilatation. Pharmacol Ther. 2014 Jun 30.

Dautov RF, Stafford I, Liu S, Cullen H, Madhani M, Chirkov YY and Horowitz JD. Hypoxic potentiation of nitrite effects in human vessels and platelets. Nitric Oxide. 2014 August; (40) 36-44.

Siddiqi N, Bruce M, Neil CJ, Jagpal B, Maclennon G , Cotton SC, Papadopoulo SA, Bunce N, Schwarz LPK, Singh S, Hildick-Smith D, Horowitz JD, Madhani M, Boon N, Kaski JC, Dawson D and Frenneaux MP. Intravenous sodium nitrite in acute ST elevation myocardial infarction: a randomised controlled trial (NIAMI). European Heart Journal 2014 May 14; 35(19):1255-62.

Borgognone A, Lowe KL, Watson SP and Madhani M. Natriuretic peptides induce weak VASP phosphorylation at Serine 239 in platelets. Platelets 2014 Mar 7.